Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

XOPENEX

LEVALBUTEROL HYDROCHLORIDE

Standard Dose
EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview XOPENEX is listed in Drugs@FDA under application 020837 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVALBUTEROL HYDROCHLORIDE Form and strength SOLUTION;INHALATION - EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HIKMA Submission history Latest submission status date: 2019-01-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview XOPENEX is listed in Drugs@FDA under application 020837 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVALBUTEROL HYDROCHLORIDE Form and strength SOLUTION;INHALATION - EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HIKMA Submission history Latest submission status date: 2019-01-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.